RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha

[1]  I. Meinhold-Heerlein,et al.  Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials , 2019, Cancers.

[2]  Y. Le,et al.  Estradiol inhibits fMLP-induced neutrophil migration and superoxide production by upregulating MKP-2 and dephosphorylating ERK. , 2019, International immunopharmacology.

[3]  O. McDonald,et al.  ERα-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer Tumorigenesis. , 2018, Cancer research.

[4]  Philippe P Roux,et al.  Signaling Pathways Involved in the Regulation of mRNA Translation , 2018, Molecular and Cellular Biology.

[5]  P. Hannaford,et al.  Contemporary Hormonal Contraception and the Risk of Breast Cancer , 2017, The New England journal of medicine.

[6]  Joonwoo Park,et al.  Hypoxia induced phosphorylation of estrogen receptor at serine 118 in the absence of ligand , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  H. Adami,et al.  Menopausal hormone therapy and cancer risk: An overestimated risk? , 2017, European journal of cancer.

[8]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[9]  B. Strassmann,et al.  Oral contraceptives cause evolutionarily novel increases in hormone exposure , 2017, Evolution, medicine, and public health.

[10]  Y. Li,et al.  Stereoselective Synthesis and Evaluation of C6″-Substituted 5a-Carbasugar Analogues of SL0101 as Inhibitors of RSK1/2. , 2017, Organic letters.

[11]  P. Mace,et al.  When Worlds Collide-Mechanisms at the Interface between Phosphorylation and Ubiquitination. , 2017, Journal of molecular biology.

[12]  J. Lundeberg,et al.  Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle , 2016, Biology of Reproduction.

[13]  Guoyao Wu,et al.  Uterine glands impact uterine receptivity, luminal fluid homeostasis and blastocyst implantation , 2016, Scientific Reports.

[14]  Y. Li,et al.  Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer , 2016, Molecular Cancer Therapeutics.

[15]  S. Das,et al.  Mechanisms of uterine estrogen signaling during early pregnancy in mice: an update. , 2016, Journal of molecular endocrinology.

[16]  M. Gallardo,et al.  Stem and progenitor cell division kinetics during postnatal mouse mammary gland development , 2015, Nature Communications.

[17]  K. Dahlman-Wright,et al.  Estrogen receptor alpha and beta in health and disease. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[18]  C. Brisken,et al.  Endocrine hormones and local signals during the development of the mouse mammary gland , 2015, Wiley interdisciplinary reviews. Developmental biology.

[19]  Madeline B. Deutsch,et al.  Effects of Cross-Sex Hormone Treatment on Transgender Women and Men , 2015, Obstetrics and gynecology.

[20]  E. Alarid,et al.  A kinetic model identifies phosphorylated estrogen receptor‐α (ERα) as a critical regulator of ERα dynamics in breast cancer , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  L. Kopelovich,et al.  Differential Roles of ERα and ERβ in Normal and Neoplastic Development in the Mouse Mammary Gland , 2014, PloS one.

[22]  K. Korach,et al.  Uterine Epithelial Cell Estrogen Receptor Alpha-Dependent and -Independent Genomic Profiles That Underlie Estrogen Responses in Mice1 , 2014, Biology of reproduction.

[23]  Jarret Glasscock,et al.  Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank , 2014, Breast Cancer Research.

[24]  J. Slingerland,et al.  Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy , 2013, Nature Reviews Cancer.

[25]  M. García-Closas,et al.  Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer , 2013, Breast Cancer Research and Treatment.

[26]  W. Han,et al.  Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer , 2012, BMC Cancer.

[27]  C. Caldas,et al.  Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland , 2012, Breast Cancer Research.

[28]  M. Wiles,et al.  Mouse Estrous Cycle Identification Tool and Images , 2012, PloS one.

[29]  A. Nusrat,et al.  Enteric Commensal Bacteria Induce Extracellular Signal-regulated Kinase Pathway Signaling via Formyl Peptide Receptor-dependent Redox Modulation of Dual Specific Phosphatase 3* , 2011, The Journal of Biological Chemistry.

[30]  J. Gustafsson,et al.  Estrogen receptors and the metabolic network. , 2011, Cell metabolism.

[31]  C. Moskaluk,et al.  Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue. , 2011, Genes & development.

[32]  W. Willett,et al.  Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[33]  C. Watson,et al.  Mammary gland growth factors: roles in normal development and in cancer. , 2010, Cold Spring Harbor perspectives in biology.

[34]  R. Lidereau,et al.  Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. , 2010, Cancer research.

[35]  T. K. Eisinger-Mathason,et al.  RSK in tumorigenesis: Connections to steroid signaling , 2010, Steroids.

[36]  L. Murphy,et al.  Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha , 2009, Breast Cancer Research and Treatment.

[37]  A. Zambrano,et al.  Activation of the unliganded estrogen receptor by prolactin in breast cancer cells , 2009, Oncogene.

[38]  H. Scharfman,et al.  Estrogen–Growth Factor Interactions and Their Contributions to Neurological Disorders , 2008, Headache.

[39]  E. Avvedimento,et al.  DNA Oxidation as Triggered by H3K9me2 Demethylation Drives Estrogen-Induced Gene Expression , 2008, Science.

[40]  B. Groner,et al.  A sparing procedure to clear the mouse mammary fat pad of epithelial components for transplantation analysis , 2008, Laboratory animals.

[41]  Simak Ali,et al.  Phosphorylation of Estrogen Receptor-α at Ser167 Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients , 2007, Clinical Cancer Research.

[42]  K. Wagner,et al.  Estrogen receptor-α expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice , 2007, Proceedings of the National Academy of Sciences.

[43]  Jérôme Eeckhoute,et al.  Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor α Expression in Breast Cancer , 2007 .

[44]  J. Fata,et al.  Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. , 2007, Reproduction.

[45]  Z. Csaba,et al.  Differences in the onset of puberty in selected inbred mouse strains , 2007 .

[46]  Luyang Sun,et al.  The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor‐regulated transcription , 2006, The EMBO journal.

[47]  Z. Darżynkiewicz,et al.  Constitutive Histone H2AX Phosphorylation and ATM Activation, the Reporters of DNA Damage by Endogenous Oxidants , 2006, Cell cycle.

[48]  E. Hrabeta-Robinson,et al.  Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system. , 2006, The Journal of endocrinology.

[49]  R. Métivier,et al.  Differential Regulation of Estrogen-Inducible Proteolysis and Transcription by the Estrogen Receptor α N Terminus , 2005, Molecular and Cellular Biology.

[50]  P. Sassone-Corsi,et al.  ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology Implication for Coffin-Lowry Syndrome , 2004, Cell.

[51]  M. Wiznerowicz,et al.  Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference , 2003, Journal of Virology.

[52]  J. Ellenberg,et al.  Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. , 2003, Molecular cell.

[53]  A. Wärri,et al.  Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Toshiyuki Fukada,et al.  Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. , 2002, Molecular cell.

[55]  J. Fata,et al.  Cellular Turnover in the Mammary Gland Is Correlated with Systemic Levels of Progesterone and Not 17β-Estradiol During the Estrous Cycle1 , 2001, Biology of reproduction.

[56]  C. Proud,et al.  Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.

[57]  Simak Ali,et al.  Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. , 2000, Molecular cell.

[58]  B. O’Malley,et al.  The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation , 2000 .

[59]  H Fang,et al.  The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[60]  B. O’Malley,et al.  Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Lannigan,et al.  Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[62]  J. Denu,et al.  Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. , 1998, Biochemistry.

[63]  J. Blenis,et al.  pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167 , 1998, Molecular and Cellular Biology.

[64]  P. Cohen,et al.  Identification of Regulatory Phosphorylation Sites in Mitogen-activated Protein Kinase (MAPK)-activated Protein Kinase-1a/p90 rsk That Are Inducible by MAPK* , 1998, The Journal of Biological Chemistry.

[65]  A. Paterson,et al.  Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. , 1997, Molecular endocrinology.

[66]  D. Picard,et al.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. , 1996, The EMBO journal.

[67]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[68]  K. Nelson,et al.  Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. , 1992, Endocrinology.

[69]  M H Liang,et al.  Oral contraceptives and the risk of rheumatoid arthritis: a meta-analysis of a conflicting literature. , 1989, British journal of rheumatology.

[70]  F. Vogel,et al.  The correlation of histologic changes in the human breast with the menstrual cycle. , 1981, The American journal of pathology.

[71]  E. Alarid,et al.  Temporal variation in estrogen receptor-α protein turnover in the presence of estrogen , 2008 .

[72]  M. C. Leske,et al.  Breast cancer and hormonal contraceptives: further results , 1996 .